May 26th, 2015|
The Tiger Paw System II is a medical device used during open-heart surgery that is manufactured by Maquet Medical Systems. The device is used to obstruct the left atrial appendage during the procedure. But numerous reports of the Tiger Paw System II causing patients serious injury have surfaced recently, and the device is being recalled and added to the U.S. Food and Drug Administration’s (FDA) list of defective medical products.
The Tiger Paw System II can tear the atrial appendage during open-heart surgery, which can lead serious bleeding. According to an FDA press release, these bleeding events have resulted in 51 reports of adverse health events and one fatality.
Facilities that use the Tiger Paw System II have been instructed to examine their inventory of devices to see if any are included in the recall. Any affected products should be removed from inventory, quarantined, and sent back to the manufacturer along with a completed recall form.
Anyone who has been harmed by the device during a surgical procedure should contact their surgeon and FDA officials to report the issue.
At Ferrer, Poirot & Wansbrough, our personal injury lawyers are here to help protect the rights of defective medical device injury victims. If you believe you were injured by the Tiger Paw System II, contact us today.
May 19th, 2015|
Mesothelioma is a deadly form of cancer of the lungs and body cavity. The disease often develops in patients who have been exposed to high levels of asbestos, a naturally occurring substance found in many of the work environments and products that are available to consumers in the United States.
There are numerous treatments to help patients battle mesothelioma, but the defective product lawyers at Ferrer, Poirot & Wansbrough explain that some of the methods are more effective than others.
A study that was released in the April issue of Oncology states that, of the 14,288 cases of mesothelioma that researchers examined, patients who underwent surgery to remove a tumor or reduce the size of the growth had the most promising survival rates.
Researchers looked at the age, sex, race, date of diagnosis, and other factors of a patient in order to divide the massive pool of participants into groups for data collection. The data determined that surgery seems to have the greatest impact on survival, while surgery combined with radiation shared similar results.
Despite improvements in medical technology and patient care, mortality rates for mesothelioma patients has not wavered from the average 18 months of life following a diagnosis.
If you’ve been diagnosed with mesothelioma, you likely have many questions regarding your rights. Speaking with a mesothelioma lawyer at Ferrer, Poirot & Wansbrough can help.
October 15th, 2013|
October 15, 2013
The citizens of the United States depend on the federal government for the safety of the medications and medical devices we use on a daily basis. Since lawmakers have been mired in conflict, resulting in a government shutdown, many citizens have become concerned over who is examining and inspecting the products we are using.
The Drug Injury Lawyers with the law firm of Ferrer, Poirot & Wansbrough state the U.S. Food and Drug Administration (FDA) recently released a statement regarding what the organization would continue to do through the shutdown and what it would not. The press release claimed the FDA would only continue work on matters of public safety and law enforcement. The agency also stated it would engage in any activities that are funded through carryover balances of user fees.
In regards to drug and Defective Medical Device investigations, the FDA has stated that certain submissions will continue to be examined, while others will not.
With certain activities not be performed by the agency during the shutdown, public safety could be put in jeopardy. Both new and old medications may not be properly inspected due to furloughs and budget cuts.
The law firm’s team of attorneys recognize the devastating effects the government shutdown could have on public health and is hopeful lawmakers can come to a resolution soon in order to prevent anyone from being harmed.
May 21st, 2013|
May 21, 2013
The results of a new Yale University study on Medtronic® Infuse Bone Graft Dangers are scheduled to be released next month. Most experts believe the findings will only support prior research that has shown significant risk in use of the product.
The Infuse Bone Graft system is a synthetic liquid form of a protein that is used to accelerate bone growth. The liquid is used in spinal and neck surgeries to help fuse bones and implants together. The product is surgically implanted into a patients body by placing a sponge that is soaked in the product between the affected vertebrae.
The problem with the system is the numerous side effects patients have reported, which include:
- Airway or Neurological Structure Compression
- Development of Certain Cancers
It was brought to light several years ago that doctors and researchers essentially swept these dangers under the rug during clinical trials because Medtronic was paying them. An article from Drug Injury Watch highlighted several instances of this behavior. Now, a well-known Yale cardiologist is reviewing all of the prior research to determine whether it was flawed.
The revelation of such issues leave many patients who had the product used on the during a surgical procedure wondering what action they should take if they were harmed.
The Defective Medical Device Lawyers with Ferrer, Poirot & Wansbrough suggest any patient who suffered negative affects from the use of the Infuse Bone Graft system should discuss their legal options with an attorney.